Pharmaceutical - Professional Development Brief

Treating COVID-19: A pharmaceutical executive’s view

McKinsey

MAY 27, 2020

Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients.

Pharmaceutical

Pharmaceutical Medical

How to improve your life with pharmaceuticals

Penelope Trunk

FEBRUARY 22, 2012

When I was 27, why was I not finding fun pharmaceuticals to improve my wellbeing? Judge your pharmaceutical choices by deciding if you attract good people when you are on the medication. At 9:30 she felt a tightening in her stomach and a rush in the front of her head. At 9:50 she called me.

Pharmaceutical

Pharmaceutical Medical IT Career

Can a Japanese pharmaceutical become a social innovator?

McKinsey

MARCH 2, 2021

Santen CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health.

Pharmaceutical

Pharmaceutical IT Medical

First-time launchers in the pharmaceutical industry

McKinsey

FEBRUARY 12, 2021

Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time?

Pharmaceutical

Pharmaceutical IT Medical

A ‘GOLD standard’ in brand growth for Japan’s pharmaceutical market

McKinsey

SEPTEMBER 17, 2020

Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth.

Pharmaceutical

HR Challenges in the Pharmaceutical Industries

Vantage Circle

MAY 10, 2021

All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. With the constant layoffs, corporate mergers and acquisitions in the pharmaceutical market, and rise in the compensation standards, many businesses have also adopted an outsourcing business model. Development in Technology.

Pharmaceutical

Pharmaceutical Healthcare Motivation Development

Four ways pharma companies can make their supply chains more resilient

McKinsey

SEPTEMBER 23, 2021

Pharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.

Pharmaceutical

Pharmaceutical Management Management

Treating rare diseases: How digital technologies can drive innovation

McKinsey

FEBRUARY 27, 2023

Pharmaceutical companies are using recent advances in digital technologies to improve care strategies and provide hope for rare disease patients across thousands of different rare diseases.

Pharmaceutical

Pharmaceutical Strategy

Pharma’s digital Rx: Quantum computing in drug research and development

McKinsey

JUNE 18, 2021

Pharmaceutical companies should reflect on their strategic stance to this promising new technology now. Quantum computing’s ability to simulate larger, more complex molecules could be game changing.

Pharmaceutical

Pharmaceutical Development Medical

The race to create a vaccine: A conversation with Frank D’Amelio

McKinsey

DECEMBER 10, 2021

The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine.

Pharmaceutical

Pharmaceutical Development IT Finance

Advancing real-world evidence for pharmaceutical companies in Japan

McKinsey

JULY 21, 2022

Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.

Pharmaceutical

How Precision Medicine Will Transform the Pharmaceutical and Healthcare Industries

Strategy+Business

FEBRUARY 22, 2018

And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles. Precision medicine combines business opportunities with clinical health benefits.

Pharmaceutical

Pharmaceutical Healthcare

Designing an agile transformation in pharma R&D

McKinsey

JULY 23, 2019

Pharmaceutical companies are increasingly turning to the concept of agility to help them transform their R&D functions.

Pharmaceutical

Pharmaceutical Medical

Should sub-Saharan Africa make its own drugs?

McKinsey

JANUARY 11, 2019

A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals to be a mixed bag.

Pharmaceutical

Pharmaceutical IT

Health equity: A framework for the epidemiology of care

McKinsey

MARCH 21, 2022

Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust.

Pharmaceutical

Improving patient adherence through data-driven insights

McKinsey

DECEMBER 15, 2018

A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue. When patients fail to follow prescribed medical regimens, outcomes suffer.

Pharmaceutical

Pharmaceutical Medical

Shaking up the value chain

McKinsey

AUGUST 16, 2018

Data and digitization are creating a growing array of value-creation choices in industries as diverse as pharmaceuticals, mining, and energy.

Pharmaceutical

Pharmaceutical Mining

What’s behind the pharmaceutical sector’s M&A push

McKinsey

OCTOBER 11, 2018

There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios.

Pharmaceutical

Pharmaceutical Finance Strategy

Data Analytics and Healthcare Innovation: Insights from Najat Khan

Correlation One

APRIL 7, 2022

of the Janssen Pharmaceutical Companies of Johnson & Johnson to learn more about data and healthcare innovation. Meet Najat Khan, Ph.D.

Healthcare

Healthcare Pharmaceutical

How to succeed as a chief digital officer in pharma

McKinsey

MARCH 10, 2017

We spoke to ten digital leaders at global pharmaceutical companies to understand how they focus their efforts. The life-sciences industry is embracing digital to unlock innovation.

Pharmaceutical

Developing pharmaceutical launch leaders and company-wide capabilities at scale

McKinsey

AUGUST 4, 2022

By building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but also strengthen their organizations for the future.

Pharmaceutical

Pharmaceutical Development Leadership

Embedding ‘smart quality’ culture and capabilities in the organization

McKinsey

JANUARY 10, 2022

Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities.

Pharmaceutical

Pharmaceutical Medical Strategy Leadership

Roche’s Infinity model: Helping to transform the lives of patients with rare diseases

McKinsey

JULY 15, 2021

Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery.

Pharmaceutical

Pharmaceutical Healthcare Medical Development

Bioelectronics ‘jump-start’ the next wave of device therapeutics

McKinsey

OCTOBER 4, 2019

Blurring the lines between pharmaceuticals and medical technology, cybermedicine has the potential to become a pillar of medical treatment and play a key role in the future of medtech innovation.

Pharmaceutical

Pharmaceutical Medical

Ready for launch: Reshaping pharma’s strategy in the next normal

McKinsey

DECEMBER 15, 2020

As pharmaceutical companies reshape their commercial models to prepare for the uncertainties ahead, personalization and digital enablement will be crucial to launch success in the new environment.

Pharmaceutical

Pharmaceutical Strategy Medical

Voices of CEO excellence: Merck’s Ken Frazier

McKinsey

JUNE 12, 2023

The former CEO and executive chairman of the pharmaceutical company offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.

Pharmaceutical

Pharmaceutical Finance Strategy Leadership

How Asia’s largest pharma is leveraging its values to navigate the COVID-19 crisis

McKinsey

JULY 31, 2020

Christophe Weber, CEO of Takeda Pharmaceuticals, discusses challenges to globalization, principles in the face of crises, and new opportunities when companies pull together.

Pharmaceutical

Pharmaceutical IT Finance Strategy

15 Things overachievers do

Penelope Trunk

DECEMBER 25, 2012

They use pharmaceuticals. Pharmaceutical frenzy is nothing new for gen-yers who used prescription drugs to get a leg up on everything. Pharmaceutical frenzy is nothing new for gen-yers who used prescription drugs to get a leg up on everything. They let doors shut all the time.

Pharmaceutical

Pharmaceutical Mentor Education Performance

A new prescription for M&A in pharma

McKinsey

SEPTEMBER 16, 2020

Adopting a through-cycle approach to deal making in the wake of the COVID-19 pandemic can position pharmaceutical companies for greater success in the next normal.

Pharmaceutical

Appreciating Differences: Leveraging Innovation in Cross-cultural Work Environments

International Coach Academy

JUNE 22, 2022

Take companies in the global pharmaceutical industry as an example. 2020), Cultural diversity drives innovation: modeling in the global pharmaceutical industry , International Journal of Innovation Science, Vol. Then, together the crew can create values based on the conversation and increase mutual understanding. Jones et al.,

Pharmaceutical

Pharmaceutical Communication Leadership Company Culture

Making quality assurance smart

McKinsey

JANUARY 29, 2021

Pharmaceutical and medtech companies can dramatically improve quality assurance processes by applying a ‘smart quality’ lens and cutting-edge technologies.

Pharmaceutical

Pharmaceutical Medical

CROs and biotech companies: Fine-tuning the partnership

McKinsey

JUNE 9, 2022

Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). How can CROs raise their game with this key segment?

Pharmaceutical

Unleashing the power of entrepreneurship in science

McKinsey

DECEMBER 6, 2016

A partner of venture-capital firm Atlas Venture, Bruce Booth, explains how investment assists pharmaceutical innovation.

Pharmaceutical

Developing a customer-centric approach to rare conditions

McKinsey

SEPTEMBER 20, 2022

Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals.

Pharmaceutical

Pharmaceutical Healthcare Development Medical

Innovating at the speed of the 21st century in pharmaceuticals

McKinsey

OCTOBER 27, 2017

The CEO of Eli Lilly offers perspectives on accelerating change in the industry.

Pharmaceutical

The hidden value of improved capital-expenditure management in pharma

McKinsey

AUGUST 13, 2019

Pharmaceutical companies can reap huge rewards from the hundreds of smaller projects they manage, not just from the occasional big one. Thinking about value, not just costs, is key.

Pharmaceutical

Pharmaceutical Management Management

How pharma companies can better understand patients

McKinsey

MAY 4, 2016

Here’s how pharmaceutical companies can better understand the way people make decisions about their care. Consumers have access to more healthcare information than ever.

Pharmaceutical

Pharmaceutical Healthcare

Thermo Fisher Scientific CEO Marc Casper on provisioning the front lines in the pandemic

McKinsey

MAY 20, 2020

Governments, healthcare providers, and pharmaceutical companies are battling COVID-19 on different fronts. Thermo Fisher Scientific is at the nexus of all of these endeavors.

Pharmaceutical

Pharmaceutical Healthcare Government Medical

From bench to bedside: Transforming R&D labs through automation

McKinsey

MARCH 8, 2023

Laboratory technology has been a steady runner in the world of pharmaceuticals, rather than a racing star—until now. A series of innovations points toward exponential gains in R&D productivity.

Pharmaceutical

How new biomolecular platforms and digital technologies are changing R&D

McKinsey

JULY 31, 2018

By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry.

Pharmaceutical

Pharmaceutical Development Medical

‘Stay grounded, stay humble’: Sanofi CEO Paul Hudson

McKinsey

JANUARY 11, 2023

In the wake of the COVID-19 pandemic, one of the first non-French leaders of the pharmaceutical company Sanofi explains cultural transformations, the growth of AI in decision making, and how he stays humble.

Pharmaceutical

s+b Trend Watch: The Coming Digital Healthcare Landscape

Strategy+Business

MAY 11, 2014

Looking toward the future, pharmaceutical companies and other stakeholders will adopt existing technologies and develop new ones, creating a more connected digital healthcare ecosystem.' Doctors and patients are starting to use digital tools to manage healthcare more efficiently.

Healthcare

Healthcare Pharmaceutical Development Management

Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?

McKinsey

SEPTEMBER 1, 2018

Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.

Pharmaceutical

Pharmaceutical Medical

Bringing an animal health business into the fold

McKinsey

AUGUST 3, 2018

Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s deal with Sanofi to acquire its animal health business.

Pharmaceutical

Pharmaceutical IT

Treating COVID-19: A pharmaceutical executive’s view

How to improve your life with pharmaceuticals

Trending Sources

Can a Japanese pharmaceutical become a social innovator?

First-time launchers in the pharmaceutical industry

A ‘GOLD standard’ in brand growth for Japan’s pharmaceutical market

HR Challenges in the Pharmaceutical Industries

Four ways pharma companies can make their supply chains more resilient

Treating rare diseases: How digital technologies can drive innovation

Pharma’s digital Rx: Quantum computing in drug research and development

The race to create a vaccine: A conversation with Frank D’Amelio

Advancing real-world evidence for pharmaceutical companies in Japan

How Precision Medicine Will Transform the Pharmaceutical and Healthcare Industries

Designing an agile transformation in pharma R&D

Should sub-Saharan Africa make its own drugs?

Health equity: A framework for the epidemiology of care

Improving patient adherence through data-driven insights

Shaking up the value chain

What’s behind the pharmaceutical sector’s M&A push

Data Analytics and Healthcare Innovation: Insights from Najat Khan

How to succeed as a chief digital officer in pharma

Developing pharmaceutical launch leaders and company-wide capabilities at scale

Embedding ‘smart quality’ culture and capabilities in the organization

Roche’s Infinity model: Helping to transform the lives of patients with rare diseases

Bioelectronics ‘jump-start’ the next wave of device therapeutics

Ready for launch: Reshaping pharma’s strategy in the next normal

Voices of CEO excellence: Merck’s Ken Frazier

How Asia’s largest pharma is leveraging its values to navigate the COVID-19 crisis

15 Things overachievers do

A new prescription for M&A in pharma

Appreciating Differences: Leveraging Innovation in Cross-cultural Work Environments

Making quality assurance smart

CROs and biotech companies: Fine-tuning the partnership

Unleashing the power of entrepreneurship in science

Developing a customer-centric approach to rare conditions

Innovating at the speed of the 21st century in pharmaceuticals

The hidden value of improved capital-expenditure management in pharma

How pharma companies can better understand patients

Thermo Fisher Scientific CEO Marc Casper on provisioning the front lines in the pandemic

From bench to bedside: Transforming R&D labs through automation

How new biomolecular platforms and digital technologies are changing R&D

‘Stay grounded, stay humble’: Sanofi CEO Paul Hudson

s+b Trend Watch: The Coming Digital Healthcare Landscape

Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?

Bringing an animal health business into the fold

Stay Connected